Yuki Ishimoto joined JAFCO in 2023, where he focuses on investments and support for R&D-oriented startups in Investment Group for Academy & Life Science.
Prior to joining JAFCO, he was involved in in-licensing/out-licensing activity at Ono Pharmaceutical's Business Development Division and its U.S. subsidiary. He also engaged in examining Asian market for the company’s expansion and supported the operations of local subsidiaries at its International Business Division.
Yuki graduated from Azabu University’s School of Veterinary Medicine and holds an MBA from HEC Paris.